NVDA

174.79

-0.87%↓

AVGO.US

323.63

+4.15%↑

ORCL

141.54

-1.82%↓

369.01

-2.02%↓

CSCO

80.12

+0.59%↑

NVDA

174.79

-0.87%↓

AVGO.US

323.63

+4.15%↑

ORCL

141.54

-1.82%↓

369.01

-2.02%↓

CSCO

80.12

+0.59%↑

NVDA

174.79

-0.87%↓

AVGO.US

323.63

+4.15%↑

ORCL

141.54

-1.82%↓

369.01

-2.02%↓

CSCO

80.12

+0.59%↑

NVDA

174.79

-0.87%↓

AVGO.US

323.63

+4.15%↑

ORCL

141.54

-1.82%↓

369.01

-2.02%↓

CSCO

80.12

+0.59%↑

NVDA

174.79

-0.87%↓

AVGO.US

323.63

+4.15%↑

ORCL

141.54

-1.82%↓

369.01

-2.02%↓

CSCO

80.12

+0.59%↑

Kodu・Aktsiate loetelu・Marqeta Inc (Class A)

Marqeta Inc (Class A)

Avatud

SektorTehnoloogia

3.96 -1

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.93

Max

4.04

Põhinäitajad
By Trading Economics
Sissetulek	2.2M -1.4M
Müük	8.8M 172M
Kasumimarginaal	-0.81
Töötajad	938
EBITDA	-3.3M 3.5M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+27.2% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-60M 1.8B
Eelmine avamishind	4.96
Eelmine sulgemishind	3.96

Uudiste sentiment

By Acuity

34%

66%

96 / 375 Pingereas Technology

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

3.975 / N/A Toetus ja vastupanu

Marqeta Inc (Class A) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk

Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk

Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

Marqeta Inc (Class A) Prognoos

Hinnasiht

By TipRanks

27.2% tõus

12 kuu keskmine prognoos

Keskmine 5.05 USD 27.2%

Kõrge 6 USD

Madal 4.25 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Marqeta Inc (Class A) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi Marqeta Inc (Class A) aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

3.975 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

96 / 375 Pingereas Tehnoloogia

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Marqeta Inc (Class A)

Marqeta, Inc. operates a cloud-based open application programming interface platform that delivers card issuing and transaction processing services. It offers its solutions in various verticals, including financial services, on-demand services, expense management, and e-commerce enablement, as well as buy now, pay later. Marqeta, Inc. was incorporated in 2010 and is headquartered in Oakland, California.